Exalenz Bioscience Launches H. Pylori Breath Test

Exalenz Biosciences, a Jersey City, N.J.-based GI and liver condition diagnostic medical device development company, has announced the global launch of its BreathID Hp.

Advertisement

The BreathID Hp is designed as a non-invasive, quick and accurate test for the detection of H. pylori.

More Articles on Gastroenterology:
4 GI Devices Receive FDA 510(k) Clearance in May & June
FDA Will Not Require IND for Fecal Microbiota Transplant
Endoscopy Device Market to be Worth $4.3B by 2017

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.